FDA limits use of GSK-Vir's sotrovimab for Covid-19 : compar

The US FDA has updated the EUA Fact Sheet limiting the usage of GSK and Vir's sotrovimab for Covid-19, due to the BA.2 Omicron sub-variant.

Related Keywords

New York , United States , Puerto Rico , Maine , New Hampshire , New Jersey , United Kingdom , Massachusetts , Virgin Islands , Vermont , Rhode Island , Connecticut , , Montgomery County Planning Commission Flickr Creative Commons , European Commission , Drug Administration , Regulatory Agency , Laboratory Informatics , Strategic Business Technology Consulting , Staffing Services , Crystallisation Solutions For Pharmaceutical Companies , Montgomery County Planning Commission , Creative Commons , Emergency Use Authorization , Fact Sheet , Vir Biotechnology , United Kingdom Medicines , Pharmaceutical Technology , Strategic Business , Technology Consulting ,